高级别胰腺神经内分泌肿瘤细胞学分化评估:多中心研究
多中心研究评估细胞病理学家仅凭细胞形态区分胰腺神经内分泌肿瘤分化程度的准确性,72例穿刺标本由3位专家独立诊断,与免疫组化、突变分析等支持的最终分类比较,一致率仅38%,分化差癌一致率67%高于分化好肿瘤的27%。
要点
- 仅凭细胞形态区分胰腺神经内分泌肿瘤分化程度具有挑战性。
- 分化差癌的细胞学诊断一致率高于分化好肿瘤。
- 坏死与分化差癌诊断一致相关,凋亡和成角核与分歧相关。
核心结论
- 仅基于细胞形态区分G2和G3胰腺神经内分泌肿瘤的分化程度具有挑战性,经验丰富的细胞病理学家之间也存在分歧。
研究设计与样本
- 多中心研究纳入2017年WHO分类G2和G3胰腺神经内分泌肿瘤细针穿刺标本72例,由3位细胞病理学家独立仅凭细胞形态诊断为分化好或分化差(大细胞型或小细胞型)。
- 诊断结果与基于免疫组化(RB、DAXX、ATRX蛋白表达)、靶向突变分析、既往G1/G2组织学病史和共识支持的最终分类进行比较。
主要发现
- 70例可评估病例中,分化诊断一致率为38%(15例分化好和12例分化差)。
- 最终分类为55例分化好(19例G2、31例G3、5例无法分级)和15例分化差(6例小细胞型、6例大细胞型、3例非特殊型)。
- 分化差癌的一致率高于分化好肿瘤(10/15 [67%] vs 15/55 [27%])。
- 圆形核和浆细胞样细胞与分化好病例的诊断一致相关,凋亡和成角核与分歧相关。
- 坏死与分化差病例的诊断一致相关。
临床怎么用
- 细胞病理学家应认识到仅凭形态区分胰腺神经内分泌肿瘤分化程度的局限性,需结合免疫组化和分子检测等辅助手段。
局限性
- 2例无法通过所用方法分类。
- 样本量有限,仅纳入G2和G3病例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Well-differentiated (WD) and poorly differentiated (PD) pancreatic neuroendocrine neoplasms are biologically distinct entities with different therapies and prognoses. WD neoplasms with elevated proliferation (Ki-67 > 20%) have been shown to have an overlapping histology with PD neuroendocrine carcinomas. This study compared expert cytomorphologic assessments of differentiation in pancreatic neuroendocrine neoplasms in a multi-institutional study. METHODS: Fine-needle aspiration specimens from pancreatic neuroendocrine neoplasms (grade 2 [G2] and grade 3 [G3] according to the 2017 World Health Organization classification; n = 72) were diagnosed independently by 3 cytopathologists as WD or PD (poorly differentiated large cell type [PD-L] or poorly differentiated small cell type [PD-S]) purely on the basis of cytomorphology. Their diagnoses were compared with a final classification supported by immunohistochemistry (retinoblastoma (RB), death domain- associated protein (DAXX), and α thalassemia/mental retardation syndrome X-linked (ATRX) protein expression), targeted mutation analysis (Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets), prior history of G1/G2 histology, and consensus. RESULTS: The rate of agreement on differentiation was 38% (15 WD cases and 12 PD cases) for the 70 cases included (55 WD cases [n = 19 G2, n = 31 G3, and n = 5 could not be graded] and 15 PD cases [n = 6 PD-S, n = 6 PD-L, and n = 3 PD, not otherwise specified). Two cases could not be classified by the employed methods. PD carcinomas had a higher rate of agreement (10 of 15 [67%]) than WD neoplasms (15 of 55 [27%]). Round nuclei and plasmacytoid cells were associated with agreement for WD cases, whereas apoptosis and angulated nuclei were associated with disagreement. Necrosis was associated with agreement for PD cases. CONCLUSIONS: A purely morphologic approach to the distinction between G2 and G3 pancreatic neuroendocrine neoplasms based on cytology can be challenging, with disagreement found among experienced cytopathologists. Cancer Cytopathol 2018;126:44-53. © 2017 American Cancer Society.
引用
- Sigel CS, Krauss Silva VW, Reid MD, et al. Assessment of cytologic differentiation in high-grade pancreatic neuroendocrine neoplasms: A multi-institutional study. Cancer Cytopathol. 2017. PMID: 29044913. doi:10.1002/cncy.21934
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。